gurufocus.comOCT 63 min read$STZ

Constellation Brands (STZ) Q2 Beats Estimates but Full-Year EPS

Constellation Brands (STZ) reported Q2 earnings of $3.74 per share on $2.63B revenue, beating estimates. The company lowered full-year EPS guidance to $11.20-$11.90, below market expectations. STZ offers a 3.66% dividend yield with a 38% payout ratio and 8.4% 3-year growth. GuruFocus rates STZ undervalued with a GF Score of 59/100, noting strong profitability but weak momentum. Institutional investors show cautious sentiment.

Original reporting

gurufocus.com

Published Oct 6, 2026, 9:58 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 6, 2026, 10:14 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefEarnings

Primary signal

$STZ

Bearish

high confidence

Mentioned

$STZ

Relevance

8/10

AlphAI data visualization · based on gurufocus.com

Decision brief

The 30-second read

$STZBearishMed

Why it matters

Guidance below consensus may trigger a sell‑off, but the dividend yield and valuation discount could attract long‑term income investors.

Market read

Earnings beat offset by weaker guidance creates mixed sentiment; short‑term downside risk with potential long‑term dividend appeal.

What to watch

Insider sales are modest; dividend safety and valuation gap may attract income‑focused investors.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Constellation Brands is a $19.8 B consumer defensive company with a diversified alcoholic beverage portfolio and a 3.66% dividend yield.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$STZBearishHigh confidence

Context

Constellation Brands reported Q2 earnings that beat estimates but issued full-year EPS guidance below consensus, impacting its stock price.

Expected impact

likely pressure as market prices in weaker full-year EPS outlook

Evidence & confidence

Guidance below expectations is a fresh, material fact for a large‑cap consumer defensive stock; investors typically react negatively to lowered earnings forecasts.

Market effects

Sector

May weigh on consumer defensive and alcoholic beverage peers as guidance concerns spread.

Regional

U.S. market focus; limited regional spillover.

Global

Modest, confined to beverage sector investors.

Counterpoint

What could challenge this read

The earnings beat and strong dividend yield could support a buy‑the‑dip thesis despite guidance miss.

Key entities

company
Constellation Brands Inc.
U.S. listed consumer defensive beverage producer (ticker STZ).

Read at source ← All news

NOV 2

$STZMed

Jefferies raises Constellation Brands stock price target on beer margin outlook

Jefferies raised its price target for Constellation Brands (STZ) to $142 from $135, maintaining a Hold rating. The firm cited improved beer margin outlook and recent share gains. STZ's P/E ratio is 12.09, with a PEG ratio of 0.19. The company reported Q2 net sales of $2.63B, up 6% YoY, with EPS of $3.74. Other analysts have mixed outlooks.

investing.com2 min

OCT 31

$STZMed

Judge keeps distribution deal in place after Coors warns of nine-figure losses

A Denver judge blocked Constellation Brands from canceling its distribution deal with Coors Distributing Company (CDC), a subsidiary of Molson Coors, citing potential $100M+ losses and reputational harm. CDC claims the deal is worth over nine figures. Constellation disputes CDC's claims. A hearing on CDC's lawsuit against Mark Anthony Brands is scheduled.

denverpost.com2 min

OCT 12

$STZMedAI 8/10

Constellation Brands Agrees to Buy SpikedAde for Up to $353 Million

Constellation Brands (STZ) agreed to buy SpikedAde for up to $353M, entering the 'hard hydration' alcohol segment. The deal follows Q2 results showing beer sales growth but softer retail demand. CEO Nick Fink aims to diversify, though past acquisitions have underperformed. Analysts note the deal's manageable size but caution about the category's long-term potential.

vinetur.com7 min

OCT 12

$STZMedAI 8/10

Constellation Brands reports a 26% drop in first-half wine and spirits sales

Constellation Brands reported a 26% drop in wine and spirits net sales to $308.6M for the first half of its fiscal year, largely due to 2025 divestitures. Organic sales in the segment grew 12%. Group net sales rose 1% to $5.066B, with beer sales up 4% to $4.757B. Net income increased 24% to $1.220B. The company maintained a cautious outlook for the rest of the year.

vinetur.com2 min

OCT 11

$STZHighAI 8/10

Constellation Brands: Q2 Revenue Rises 6% To $2.63 Billion As Beer And Wine And Spirits Sales Grow

Constellation Brands reported Q2 fiscal 2027 net sales of $2.63B, up 6% YoY. Beer sales rose 5% to $2.47B, while Wine and Spirits sales increased 17% to $159.4M. Operating income fell 8% to $805M, but EPS rose 25% to $3.32. The company acquired SpikedAde for $75M, with up to $278M in contingent payments. Constellation updated its fiscal 2027 EPS guidance to $11.85-$12.55 and declared a $1.03 quarterly dividend.

pulse2.com3 min

OCT 9

$LWLow

Earnings market review: beats fall short as guidance and costs drive reactions

Lamb Weston (LW) and Constellation Brands (STZ) reported earnings beats but faced mixed reactions due to guidance and cost pressures. PepsiCo (PEP) and Delta Air Lines (DAL) also reported, with DAL missing EPS estimates. Analysts note that estimate revisions, not just beats, are driving market reactions. The macro backdrop includes high yields and expensive oil, impacting earnings expectations.

uk.investing.com3 min